Financhill
Sell
41

ABT Quote, Financials, Valuation and Earnings

Last price:
$124.87
Seasonality move :
2.88%
Day range:
$123.85 - $125.18
52-week range:
$110.86 - $141.23
Dividend yield:
1.89%
P/E ratio:
15.66x
P/S ratio:
4.98x
P/B ratio:
4.26x
Volume:
7.5M
Avg. volume:
6.9M
1-year change:
8.95%
Market cap:
$217.1B
Revenue:
$42B
EPS (TTM):
$7.97

Earnings Data

Next earnings date for ABT
Jan 21
2026
Most recent earnings per share
$0.91
Missed by $0.38
(Oct 15/2025)
Consensus Estimate
$1.30
(Oct 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ABT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/21/2026 Q4 $11.8B -- -- $1.50 --
10/15/2025 Q3 $11.4B $11.4B $0.91 $1.30 -$0.38
07/17/2025 Q2 $11.1B $11.1B $1.03 $1.26 -$0.23
04/16/2025 Q1 $10.4B $10.4B $0.74 $1.07 -$0.33
01/22/2025 Q4 $11B $11B $5.29 $1.34 $3.94
10/16/2024 Q3 $10.6B $10.6B $0.94 $1.20 -$0.26
07/18/2024 Q2 $10.4B $10.4B $0.74 $1.10 -$0.36
04/17/2024 Q1 $9.9B $10B $0.70 $0.95 -$0.26
01/24/2024 Q4 $10.2B $10.2B $0.91 $1.19 -$0.28
10/18/2023 Q3 $9.8B $10.1B $0.82 $1.10 -$0.28
07/20/2023 Q2 -- $10B $0.78 -- --
04/19/2023 Q1 -- $9.7B $0.75 -- --
01/25/2023 Q4 -- $10.1B $0.59 -- --
10/19/2022 Q3 -- $10.4B $0.81 -- --
07/20/2022 Q2 -- $11.3B $1.14 -- --
04/20/2022 Q1 -- $11.9B $1.37 -- --
01/26/2022 Q4 -- $11.5B $1.11 -- --
10/20/2021 Q3 -- $10.9B $1.17 -- --
07/22/2021 Q2 -- $10.2B $0.66 -- --
04/20/2021 Q1 -- $10.5B $1.00 -- --
01/27/2021 Q4 -- $10.7B $1.21 -- --
10/21/2020 Q3 -- $8.9B $0.69 -- --
07/16/2020 Q2 -- $7.3B $0.30 -- --
04/16/2020 Q1 -- $7.7B $0.32 -- --
01/22/2020 Q4 -- $8.3B $0.59 -- --
10/16/2019 Q3 -- $8.1B $0.53 -- --
07/17/2019 Q2 -- $8B $0.56 -- --
04/17/2019 Q1 -- $7.5B $0.38 -- --
01/23/2019 Q4 -- $7.8B $0.37 -- --
10/17/2018 Q3 -- $7.7B $0.32 -- --
07/18/2018 Q2 -- $7.8B $0.41 -- --
04/18/2018 Q1 -- $7.4B $0.23 -- --
01/24/2018 Q4 -- $7.6B -$0.48 -- --
10/18/2017 Q3 -- $6.8B $0.34 -- --
07/20/2017 Q2 -- $6.6B $0.16 -- --
04/19/2017 Q1 -- $6.3B $0.24 -- --
01/25/2017 Q4 -- $5.3B $0.54 -- --
10/19/2016 Q3 -- $5.3B -$0.22 -- --
07/20/2016 Q2 -- $5.3B $0.42 -- --
04/20/2016 Q1 -- $4.9B $0.20 -- --
01/28/2016 Q4 -- $5.2B $0.51 -- --

Abbott Laboratories Earnings Questions

  • How Much did Abbott Laboratories Generate in Revenue Last Quarter?

    Abbott Laboratories reported $11.4B worth of top line sales in its most recent quarter.

  • Did Abbott Laboratories Beat Earnings Last Quarter?

    Abbott Laboratories announced earnings per share of $0.91 which represents a miss of analyst forecast a $1.30 per share.

  • Is Abbott Laboratories Profitable?

    Abbott Laboratories reported $5.9B that represents $3.38 per share over the last quarter.

  • What is the Analyst Consensus for Abbott Laboratories EPS Next Year?

    Abbott Laboratories's earnings are forecast to decrease from $7.64 per share to $4.67 per share next year representing a decrease of -32.3%.

  • When is Abbott Laboratories's Earnings Date?

    Abbott Laboratories's next earnings date is January 21, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

Sell
32
SMX alert for Dec 24

SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock